Insider Selling: Shoulder Innovations (NYSE:SI) Major Shareholder Sells $27,029.60 in Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 1,196 shares of Shoulder Innovations stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $22.60, for a total transaction of $27,029.60. Following the transaction, the insider directly owned 2,185,914 shares in the company, valued at approximately $49,401,656.40. This trade represents a 0.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.62, for a total transaction of $15,404.22.
• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total transaction of $463,866.76.
• On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total transaction of $88,140.00.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total value of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total value of $659,803.20.

Shoulder Innovations Stock Performance

Shoulder Innovations stock opened at $21.07 on Monday. The firm has a market capitalization of $438.68 million and a PE ratio of -10.97. Shoulder Innovations, Inc. has a one year low of $10.92 and a one year high of $24.59. The stock’s 50 day moving average price is $21.29 and its 200 day moving average price is $16.85. The company has a debt-to-equity ratio of 0.12, a quick ratio of 8.92 and a current ratio of 10.71.

Shoulder Innovations (NYSE:SI) last issued its quarterly earnings data on Thursday, August 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.46) by ($0.03). The firm had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. As a group, sell-side analysts expect that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.

Analyst Ratings Changes

SI has been the subject of several recent analyst reports. Weiss Ratings upgraded Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 3rd. UBS Group increased their price target on Shoulder Innovations from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, August 10th. BTIG Research raised their price objective on Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 target price (up from $19.00) on shares of Shoulder Innovations in a research report on Friday, August 7th. Five research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $25.50.

Institutional Investors Weigh In On Shoulder Innovations

Hedge funds and other institutional investors have recently modified their holdings of the stock. Rhumbline Advisers bought a new position in shares of Shoulder Innovations during the third quarter worth about $54,000. Vanguard Group Inc. bought a new stake in Shoulder Innovations in the third quarter valued at about $1,836,000. Deerfield Management Company L.P. acquired a new stake in Shoulder Innovations during the third quarter valued at approximately $6,056,000. Bank of America Corp DE acquired a new stake in Shoulder Innovations during the third quarter valued at approximately $322,000. Finally, Citadel Advisors LLC bought a new position in Shoulder Innovations during the 3rd quarter worth approximately $628,000.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.